NEW YORK (GenomeWeb News) — Cepheid and Instrumentation Laboratory intend to develop and distribute diagnostics for hemostasis applications, Cepheid said today.  
Under the agreement, Cepheid will develop tests to be used on its GeneXpert technology, while IL will market them as part of its panel of hemostasis diagnostic assays.
Cepheid said it first plans to develop the Xpert HemosIL tests to detect Factor II and Factor V mutations, which are genetic variations associated with thrombosis.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.